Testing of a Novel Optical Imaging Device for Concussion Diagnosis and Management
Summary
Concussion and brain injury are recognized as a major health issue for Canadians. This
problem may be especially severe in pediatric populations where brain injury could have life
long implications and since children are more likely than adults to have persistent symptoms.
We need better tools to quantify concussion. This method, functional near-infrared
spectroscopy (fNIRS) detects changes in hemoglobin oxygenation as a marker of brain
activity. we will use fNIRS to study functional changes in the brain of subjects following concussion.
Eligibility
Eligible gender: Male, Female, Transgender, Other
Eligible ages: 10 to 50
Accepts healthy participants: Yes
Inclusion criteria:
1. Participants must be 10-50 years old
2. Participants must either be symptomatic following a concussion injury OR healthy individuals with no history of concussion within 1 year prior
3. Participants must meet exclusion criteria
Exclusion criteria:
1. Individuals with history of neurological, psychiatric, or cerebrovascular disorder
2. Individuals taking psychoactive medication, or recreational drug use
Participate
Fill out the following form if you want to participate in this research
Collection of personal information
Your personal information is collected under
the authority of section 33(c) of the Freedom of Information and Protection of Privacy Act. If
you have any questions about the collection or use of this information, please visit our
Access to Information page.
Additional information
Contact information
Please contact our graduate student, Ibukun Oni , at 403-220-7849 or concussionscience@gmail.com
Principal investigator:
Jeffrey Dunn
Clinical trial:
No
REB-ID:
REB15-1376